miR-210 as a therapeutic target in diabetes-associated endothelial dysfunction.
Collado A, Jiao T, Kontidou E, Carvalho LRRA, Chernogubova E, Yang J, Zaccagnini G, Zhao A, Tengbom J, Zheng X, Rethi B, Alvarsson M, Catrina SB, Mahdi A, Carlström M, Martelli F, Pernow J, Zhou Z.
Collado A, et al. Among authors: catrina sb.
Br J Pharmacol. 2025 Jan;182(2):417-431. doi: 10.1111/bph.17329. Epub 2024 Oct 14.
Br J Pharmacol. 2025.
PMID: 39402703